# 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

> **NCT05099536** · PHASE1 · WITHDRAWN · sponsor: **3D Medicines (Beijing) Co., Ltd.**

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** 3D011-08

## Key facts

- **NCT ID:** NCT05099536
- **Lead sponsor:** 3D Medicines (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-24
- **Primary completion:** 2023-09-11
- **Final completion:** 2023-09-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company's decision
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05099536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05099536, "3D011-08 Monotherapy in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05099536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*